AdaptHealth (AHCO) CFO awarded 126,899 restricted stock unit shares

Rhea-AI Filing Summary

AdaptHealth Corp.'s Chief Financial Officer, Jason A. Clemens, reported an equity award of company stock. On January 30, 2026, he acquired 126,899 shares of Common Stock at a price of $0 per share, bringing his directly held beneficial ownership to 673,481 shares.

The newly reported shares represent restricted stock units that will be settled in common stock when they vest, providing the CFO with additional long-term, stock-based compensation tied to the company’s performance and continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Clemens Jason A

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	126,899	$0.00	--

Holdings After Transaction: Common Stock — 673,481 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clemens Jason A

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		126,899(1)	A	$0	673,481	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Jason Clemens	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AdaptHealth (AHCO) disclose for its CFO?

AdaptHealth disclosed that CFO Jason A. Clemens acquired 126,899 shares of Common Stock. These shares come from restricted stock units that will convert into common stock upon vesting, increasing his directly held beneficial ownership stake in the company.

How many AdaptHealth (AHCO) shares does the CFO own after this Form 4?

After the reported transaction, CFO Jason A. Clemens beneficially owns 673,481 shares of AdaptHealth common stock directly. This total includes the 126,899 restricted stock unit shares that were granted and are scheduled to settle in common stock upon vesting.

What type of equity did the AdaptHealth (AHCO) CFO receive on January 30, 2026?

On January 30, 2026, the AdaptHealth CFO received restricted stock units representing 126,899 shares of common stock. These RSUs will be settled in common stock once they vest, aligning his compensation more closely with the company’s long-term stock performance.

At what price were the AdaptHealth (AHCO) CFO’s new shares acquired?

The 126,899 shares reported for the AdaptHealth CFO were acquired at a price of $0 per share. This reflects an equity award of restricted stock units rather than an open-market purchase, with settlement in common stock upon vesting conditions being met.

Does the AdaptHealth (AHCO) Form 4 involve direct or indirect ownership?

The Form 4 reports that Jason A. Clemens holds these AdaptHealth shares as direct beneficial ownership. The 673,481 total common shares, including those from restricted stock units, are classified as directly owned rather than through an intermediary entity or indirect structure.